HCTI Healthcare Triangle, Inc.
Price Chart
Executive Summary
This is an amended 10-K filing solely to correct a clerical error in the auditor's signature on the audit report. The amendment does not reflect any changes to the financial statements or disclosures beyond restating the audit report. The original filing contained significant financial deterioration, including a 59% increase in net loss to $9.5 million, negative cash flow of $16.5 million, and substantial dilution through convertible debt and equity financings.
Actionable Insight
Despite the technical nature of this amendment, traders should be concerned about the company's deteriorating fundamentals including massive losses, high leverage through convertible debt, and related party transactions. The significant capital raising through dilutive instruments suggests ongoing liquidity challenges despite the cash balance increase.
Key Facts
- Amendment is solely for correcting auditor's signature - no financial restatements
- Net loss increased 59% to $9.476 million in 2025 from $5.969 million in 2024
- Cash and cash equivalents increased to $7.6 million from $20 thousand due to equity and debt financing
- Company issued $10.5 million in convertible notes and raised $17 million through equity issuances
- Significant related party transactions with SecureKloud entities totaling over $3 million
- Company has $10.7 million in short-term borrowing, up from $2.6 million
Financial Impact
The company incurred $9.5 million in net losses with $16.5 million in negative operating cash flow, offset by $25.9 million in financing activities primarily from convertible debt ($10.5 million) and equity issuances ($17 million)
Risk Factors
- Substantial doubt about going concern due to accumulated deficits and negative cash flows
- High exposure to convertible debt that could lead to significant shareholder dilution
- Material related party transactions that may not be at arm's length
Market Snapshot
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001213900-26-044671 |
| Document: ea028670501ex31-1.htm | 0001213900-26-044671 |
| Document: ea028670501ex31-2.htm | 0001213900-26-044671 |
| Document: ea028670501ex32-1.htm | 0001213900-26-044671 |
| Document: ea028670501ex32-2.htm | 0001213900-26-044671 |
| Document: 0001213900-26-044671-index-headers.html | 0001213900-26-044671 |
| Document: 0001213900-26-044671-index.html | 0001213900-26-044671 |
| Document: 0001213900-26-044671.txt | 0001213900-26-044671 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Apr 16, 2026
5w ago
|
10-K/A
| $2.47 $2.28 | ▲ +7.69% | ▲ +13.06% | $2.41 (+2.43%) |
|
Mar 11, 2026
10w ago
|
8-K
| $2.93 $2.40 | ▼ −18.09% | ▼ −20.06% | $2.41 (−17.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access